<strong>Purpose: </strong>Many health systems are considered ill-equipped to adequately meet future demand. Although academic entrepreneurs and small and medium-sized enterprises (SMEs) drive health techno...<strong>Purpose: </strong>Many health systems are considered ill-equipped to adequately meet future demand. Although academic entrepreneurs and small and medium-sized enterprises (SMEs) drive health technology innovation, they often suboptimally consider important market and stakeholder requirements. This can result in missed opportunities to improve health system performance, address demand-supply gaps, and achieve financial rewards. Market intelligence can provide crucial information in this regard, but scientifically sourced guidance on how to perform market research for biopharmaceutics is scarce. Our objective was, therefore, to create and provide an easily accessible biopharmaceutics market research toolbox that can be perused by academic entrepreneurs and SMEs to improve the alignment of their developments with stakeholder needs. <strong>Design: </strong>Guided by market orientation theory, we interviewed senior managers and commercialisation experts from the biopharmaceutics sector. We asked them which information they consider most relevant, and how they collect, analyse and respond to new information to align product features, positioning and stakeholder-relationship management with market needs. <strong>Findings: </strong>Our innovator toolbox consists of a high-level overview of market intelligence considerations mapped against a novel innovation framework, a stakeholder reasoning and value model, and detailed considerations (checklists) per stakeholder of biopharmaceutics interventions. <strong>Originality:</strong> We provide here the first market orientation-based overview of market intelligence considerations for the biopharmaceutics sector. Although primarily collated for academic entrepreneurs and SMEs, our innovator toolbox for the biopharmaceutics sector can help all stakeholders better understand their orientation towards markets.展开更多
2022年3月,美国国家科学基金会(National Science Foundation,NSF)成立技术、创新与伙伴关系部(Directorate of Technology,Innovation and Partnerships,TIP学部)。TIP学部将前期分散在其他部门的试点项目进行整合吸纳,在创新链条上设...2022年3月,美国国家科学基金会(National Science Foundation,NSF)成立技术、创新与伙伴关系部(Directorate of Technology,Innovation and Partnerships,TIP学部)。TIP学部将前期分散在其他部门的试点项目进行整合吸纳,在创新链条上设置培育创新环境和促进应用转化的多类项目,快速形成了资助应用基础研究的整体布局。本文介绍了该学部各项目的设置情况,并结合NSF既有项目类型和资助对象,分析阐述了新学部项目设置的优势特点。作为美国政府响应国家战略需求、加速基础研究成果应用转化的重要举措,TIP学部的成立在扩大基金资助范围、优化项目管理和促进成果转化等方面对我国自然科学基金资助应用导向基础研究提供了有益启示与借鉴。展开更多
文摘<strong>Purpose: </strong>Many health systems are considered ill-equipped to adequately meet future demand. Although academic entrepreneurs and small and medium-sized enterprises (SMEs) drive health technology innovation, they often suboptimally consider important market and stakeholder requirements. This can result in missed opportunities to improve health system performance, address demand-supply gaps, and achieve financial rewards. Market intelligence can provide crucial information in this regard, but scientifically sourced guidance on how to perform market research for biopharmaceutics is scarce. Our objective was, therefore, to create and provide an easily accessible biopharmaceutics market research toolbox that can be perused by academic entrepreneurs and SMEs to improve the alignment of their developments with stakeholder needs. <strong>Design: </strong>Guided by market orientation theory, we interviewed senior managers and commercialisation experts from the biopharmaceutics sector. We asked them which information they consider most relevant, and how they collect, analyse and respond to new information to align product features, positioning and stakeholder-relationship management with market needs. <strong>Findings: </strong>Our innovator toolbox consists of a high-level overview of market intelligence considerations mapped against a novel innovation framework, a stakeholder reasoning and value model, and detailed considerations (checklists) per stakeholder of biopharmaceutics interventions. <strong>Originality:</strong> We provide here the first market orientation-based overview of market intelligence considerations for the biopharmaceutics sector. Although primarily collated for academic entrepreneurs and SMEs, our innovator toolbox for the biopharmaceutics sector can help all stakeholders better understand their orientation towards markets.
文摘2022年3月,美国国家科学基金会(National Science Foundation,NSF)成立技术、创新与伙伴关系部(Directorate of Technology,Innovation and Partnerships,TIP学部)。TIP学部将前期分散在其他部门的试点项目进行整合吸纳,在创新链条上设置培育创新环境和促进应用转化的多类项目,快速形成了资助应用基础研究的整体布局。本文介绍了该学部各项目的设置情况,并结合NSF既有项目类型和资助对象,分析阐述了新学部项目设置的优势特点。作为美国政府响应国家战略需求、加速基础研究成果应用转化的重要举措,TIP学部的成立在扩大基金资助范围、优化项目管理和促进成果转化等方面对我国自然科学基金资助应用导向基础研究提供了有益启示与借鉴。